Rodger Novak, President at CRISPR Therapeutics AG (CRSP), sold 73,027 shares at $40.24 ($2.9M) on 2019-03-04, disclosed to the SEC on 2019-03-05.
Open-market sale of $2.9M CRSP by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.24 | 64,115 | $2.6M | 87.5% |
| 2 | $41.29 | 8,912 | $368K | 12.5% |
| Total | $40.37 avg | 73,027 | $2.9M | 100% |
| Filing → |
| CRSP | SELL | 2021-06-23 | $6.4M | — | Filing → |
| CRSP | SELL | 2020-12-02 | $6.3M | — | Filing → |
| CRSP | SELL | 2020-10-13 | $2.5M | — | Filing → |